Cell proliferation and ploidy of human solid tumours: Methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry

Analytical Cellular Pathology

Volumn 10, Issue 2, 1996, Pages 101-113

  Mazzini, G ^a   Danova, M ^a,b   Ferrari, C ^b   Giordano, M ^b   Dionigi, P ^b   Riccardi, A ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

DNA BrdU cytokeratin; Flow cytometry; Proliferation; Solid tumours

Indexed keywords

BROXURIDINE; DNA;

ARTICLE; CANCER; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; SOLID TUMOR;

BROMODEOXYURIDINE; CELL DIVISION; DNA, NEOPLASM; FEASIBILITY STUDIES; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL NEOPLASMS; GLIOMA; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS; OVARIAN NEOPLASMS; PLOIDIES; UTERINE NEOPLASMS;

EID: 0029940130     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich EJ. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982-3997.
2. Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620-625.
3. Begg AC, Hofland I. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry. Cytometry 1991; 12: 445-454.
4. Benazzo M, Mevio E, Occhini A, Franchini G, Danova M. Proliferative characteristics of head and neck tumors: in vivo evaluation by bromodeoxyuridine incorporation and flow cytometry. ORL 1995; 57: 39-43.
5. Brons P, Raemaekers JMM, Bogman JTJ, van Erp PEJ, Boezeman JBM, Pennings AHM, Wessels HMC, Haanen C. Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining and flow cytometry. Blood 1992; 80: 2336-2343.
6. Brooks DJ, Garewal HS. Measures of tumor proliferative activity. Int J Clin Lab Res 1992; 22: 196-200.
7. Corvo' R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V. Potetial doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys 1993; 27: 1165-1172.
8. Crissman HA, Tobey RA. Cell cycle analysis in 20 min. Science 1974; 184: 1297-1301.
9. Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Scwarz E, Koss LG. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J Histochem Cytochem 1990; 38: 463-466.
10. Danova M, Wilson GD, Riccardi A, Mazzini G, Ucci G, Giordano M, Brugnatelli S, Luoni R, McNally NJ, Ascari E. In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies. Haematologica 1987; 72: 115-119.
11. Danova M, Riccardi A, Mazzini G. Cell cycle-related proteins and flow cytometry. Haematologica 1990; 75: 251-258.
12. Danova M, Riccardi A, Ucci G, Luoni M, Giordano M, Mazzini G. Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study. Br J Cancer 1990; 62: 781-785.
13. Danova M, Mazzini G, Giordano M, Ferrari C. Bromodeoxyuridine-based methods for cell kinetic studies in human tumors. Appl Fluor Technol 1991; 3: 1-10.
14. Danova M, Gaetani P, Lombardi D, Giordano M, Riccardi A, Mazzini G. Prognostic value of DNA ploidy and proliferative activity in human malignant gliomas. Med Sci Res 1991; 19: 613-615.
15. Danova M, Giaretti W, Merlo F, Mazzini G, Gaetani P, Geido E, Gentile S, Butti G, Di Vinci A, Riccardi A. Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int J Cancer 1991; 48: 663-667.
16. Darzynkiewicz Z. Cellular RNA content, a feature correlated with cell kinetics and tumor prognosis. Leukemia 1988; 2: 777-787.
17. Erba E, Giordano M, Danova M, Mazzini G, Ubezio P, Torri W, Mangioni C, Landoni F, Bolis P, Tenti P, Franchi M, Babilonti L, Riccardi A, D'Incalci M. Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine. Ann Oncol 1994; 5: 627-634.
18. Ferreo M, Spyratos F, Le Doussal V, Desplacies A, Rouesse' J. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK 19, and KL 1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry 1990; 11: 716-720.
19. Franchini G, Tusei A, Babilonti L, Donadello N, Franchi M, Zanaboni F, Tateo S, Mazzini G, Riccardi A, Danova M. DNA ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. Oncol Rep 1994; 1: 65-67.
20. Giordano M, Riccardi A, Danova M, Brugnatelli S, Mazzini G. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry. Cancer Det Prev 1991; 20: 391-396.
21. Gohde W. Automation of cytofluorometry by use of the impulsemicrophotometer. In: Thaer A, Sernetz M, eds. Fluorescence techniques in cell biology. New York: Springer-Verlag, 1972; 79-88.
22. Gratzner HG. Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474-479.
23. Gray JW. Monoclonal antibodies against bromodeoxyuridine. Cytometry 1985; 6: 499-504.
24. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet 1990; 23: 505-522.
25. Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson B, Davis RL, Wilson CB. Cell kinetic analysis of human brain tumors by in situ double labelling index with bromodeoxyuridine and iododeoxyuridine. Int J Cancer 1992; 50: 1-5.
26. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell-cycle by propidium iodide staining. J Cell Biol 1975; 66: 188-192.
27. Kute TE, Quadri Y. Measurement of proliferation nuclear and membrane markers in tumor cells by flow cytometry. J Histochem Cytochem 1991; 39: 1125-1130.
28. Mazzini G, Giordano P, Riccardi A, Montecucco CM. A flow cytometric study of the propidium iodide staining kinetics of human leukocytes and its relationship with chromatin structure. Cytometry 1983; 3: 443-448.
29. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-16.
30. Orfao A, Ruiz-Arguelles A, Lacombe F, Ault K, Basso G, Danova M. Flow cytometry: its applications in haematology. Haematologica 1995; 80: 69-81.
31. Oud PS, Henderik JBJ, Beck HLM, Veldhuizen JAM, Vooijls GP, Herman CJ, Remaekers FCS. Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labelling for cytokeratin using a monoclonal antibody. Cytometry 1985; 6: 159-164.
32. Prenna G, Leiva S, Mazzini G. Quantitation of DNA by cytofluorometry of the conventional Feulgen reaction. Histochem J 1974; 6: 467-471.
33. Rew DA, Wilson GD, Taylor I, Weaver PC. Proliferation characteristics of human colorectal carcinomas measured in vivo Br J Surg 1991; 78: 60-66.
34. Riccardi A, Danova M, Wilson GD, Ucci G, Dormer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ, Ascari E. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res 1988; 48: 6238-6245.
35. Riccardi A, Danova M, Mazzini G; Bromodeoxyuridine for cell kinetic investigations in humans. Haematologica 1988; 73: 423-430.
36. Riccardi A, Giordano M, Danova M, Girino M, Brugnatelli S, Ucci G, Mazzini G. Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur J Cancer 1991; 27: 882-887.
37. Roncucci L, Pedroni M, Scalmati A, Bormioli ML, Sassatelli R, Fante R, Losi L, Di Gregorio C, Petocchi B, Ponz De Leon M. Cell kinetic evaluation of colorectal tumors after in vivo administration of bromodeoxyuridine. Int J Cancer 1992; 52: 856-861.
38. Sandritter W, Carl M, Ritter W. Cytophotometric measurements of the DNA content of human malignant tumors by means of the Feulgen reaction. Acta Cytol 1966; 10: 26-30.
39. Stewart CC. Flow cytometric analysis of oncogene expression in human neoplasia. Arch Pathol Lab Med 1989; 113: 634-640.
40. Vindelov LL, Christensen IC. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 1990; 11: 753-758.
41. Waldman MW, Dolbeare F, Gray J. Clinical applications of the bromodeoxyuridine/DNA assay. Cytometry 1988; 3 (Suppl.): 65-72.
42. Watson JV. Oncogenes, cancer and analytical cytology. Cytometry 1986; 7: 400-410.
43. Wilson GD, McNally NJ, Dunphy E, Karcher H, Pfragner R. The labelling index of human and mouse tumours assessed by Bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 1985; 6: 641-647.
44. Wilson MS, West CM, Wilson GD, Roberts SA, James RD, Schofield PF. Intratumoral heterogeneity of tumour potential doubling times (Tpot) in clorectal cancer. Br J Cancer 1993; 68: 501-506.
45. White RA, Terry NHA, Meistrich ML, Calkins DP. An improved method for computing the potential doubling time using monoclonal antibodies to bromodeoxyuridine. Cytometry 1990; 11: 314-317.